1-8 of 8
Helena Almeida
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Evaluation of Peroxiredoxins (PRDX1, PRDX2 and PRDX6) Expression in Patients with Chronic Myeloid Leukemia (CML) Treated with Imatinib in First Line

Cintia Mascarenhas, Lara Woldmar, Maria Helena Almeida, PhD, Rosangela Vieira Andrade, PhD, Anderson Ferreira Cunha, Carmino A De Souza, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5545.
https://doi.org/10.1182/blood.V124.21.5545.5545
Published: 2014
Journal Articles

Evaluation Of hOCT1expression In Patients With Chronic Myeloid Leukemia (CML) Treated With Imatinib In First Line

Cintia Do Couto Mascarenhas, PhD, Maria Helena Almeida, PhD, Eliana C M Miranda, MEd, Bruna Virgilio, Marcia Torresan Delamain, MD, Gislaine O. Duarte, PhD, Vagner O Duarte, Carmino A De Souza, Sr., MD, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4041.
https://doi.org/10.1182/blood.V122.21.4041.4041
Published: 2013
Journal Articles

Treatment Results With Dasatinib Or Nilotinib In Third Line Therapy Of Chronic Myeloid Leukemia After Failure Of Two Tyrosine Kinase Inhibitors

Beatriz F Ribeiro, Eliana C M Miranda, MEd, Marcia T Delamain, MD, Gislaine Borba Oliveira, MD,, Maria Helena Almeida, RN, Vagner O Duarte, Irene L Metze, MD, PhD, Carmino A De Souza, Sr., MD, PhD, Rosana A Silveira, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 5189.
https://doi.org/10.1182/blood.V122.21.5189.5189
Published: 2013
Journal Articles

Early Molecular Response Is Predictive Of Overall, Progression-Free and Event-Free Survival In Chronic Myeloid Leukemia Using Second-Generation Tyrosine Kinase Inhibitors After Imatinib Treatment

Beatriz F Ribeiro, Bruna Vergilio, Eliana C M Miranda, MEd, Maria Helena Almeida, RN, Marcia Torresan Delamain, MD, Rosana A Silveira, MSc, Carmino A De Souza, Sr., MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Andrey dos Santos, PhD, Irene Lorand-Metze, MD, PhD, Vagner O Duarte, Gislaine O. Duarte, PhD, Katia B. Pagnano, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1326.
https://doi.org/10.1182/blood.V122.21.1326.1326
Published: 2013
Journal Articles

High Adherence to Tyrosine Kinase Inhibitors Seems to Be Related to Best Cytogenetic Responso In the Hasford Lower Risk Graup In Chronic Myeloid Leukemia.

Maria Helena Almeida, RN, Katia B. Pagnano, MD, Helia Souza, Eliana C M Miranda, Carmino De Souza, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 4477.
https://doi.org/10.1182/blood.V116.21.4477.4477
Published: 2010
Journal Articles

Sequence Analysis of MPL Exon 10 of ET and MF JAK2 V617F Negative Patients Reveals a New Mutation

Celeste Bento, Marta Duarte, Helena Almeida, Cristina Menezes, Alexandra Estevinho, Margarida Coucelo, Jaspal Kaeda, Maria Leticia Ribeiro, MD, PhD
Journal: Blood
Blood (2008) 112 (11): 5254.
https://doi.org/10.1182/blood.V112.11.5254.5254
Published: 2008
Journal Articles

Severe hereditary spherocytosis and distal renal tubular acidosis associated with the total absence of band 3

Brief Report
Maria Letı́cia Ribeiro, Nicole Alloisio, Helena Almeida, Clara Gomes, Pascale Texier, Carlos Lemos, Gabriela Mimoso, Laurette Morlé, Faı̈za Bey-Cabet, René-Charles Rudigoz, Jean Delaunay, Gabriel Tamagnini
Journal: Blood
Blood (2000) 96 (4): 1602–1604.
https://doi.org/10.1182/blood.V96.4.1602
Published: 2000
Journal Articles

Elliptocytosis in patients with C - terminal domain mutations of protein 4.1 correlates with encoded messenger RNA levels rather than with alterations in primary protein structure

Madeleine Morinière, Leticia Ribeiro, Nicole Dalla Venezia, Mireille Deguillien, Philippe Maillet, Thérèse Cynober, François Delhommeau, Helena Almeida, Gabriel Tamagnini, Jean Delaunay, Faouzi Baklouti
Journal: Blood
Blood (2000) 95 (5): 1834–1841.
https://doi.org/10.1182/blood.V95.5.1834
Published: 2000